financetom
Business
financetom
/
Business
/
Cytokinetics Q4 Net Loss Narrows, Revenue Rises
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Cytokinetics Q4 Net Loss Narrows, Revenue Rises
Feb 27, 2025 1:18 PM

04:09 PM EST, 02/27/2025 (MT Newswires) -- Cytokinetics ( CYTK ) reported a Q4 net loss Thursday of $1.26 per diluted share, narrowing from the loss of $1.38 a year earlier.

Analysts polled by FactSet expected a loss of $1.19.

Revenue in the three months ended Dec. 31 jumped to $16.9 million from $1.67 million a year earlier.

Analysts surveyed by FactSet expected $1.7 million.

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
U.S. consumer watchdog probes major US banks over Zelle scam, WSJ reports
U.S. consumer watchdog probes major US banks over Zelle scam, WSJ reports
Aug 7, 2024
Aug 7 (Reuters) - The Consumer Financial Protection Bureau (CFPB) is investigating major U.S. banks for their handling of customer funds on the peer-to-peer payments platform Zelle, the Wall Street Journal reported on Wednesday. The probe focuses on JPMorgan ( JPM ), Bank of America ( BAC ) and Wells Fargo ( WFC ) among other large banks, the report...
Triumph Group Shares Fall After Reporting Fiscal Q1 Results
Triumph Group Shares Fall After Reporting Fiscal Q1 Results
Aug 7, 2024
10:25 AM EDT, 08/07/2024 (MT Newswires) -- Triumph Group ( TGI ) shares fell more than 11% in recent Wednesday trading after the company's fiscal Q1 adjusted loss came in wider than expected. The company reported fiscal Q1 adjusted loss from continuing operations of $0.06 per diluted share, narrowing from a loss of $0.16 a year earlier. Analysts polled by...
Crescita Therapeutics Down 4.5% As Reports Wider Q2 Net Loss On Lower Revenues
Crescita Therapeutics Down 4.5% As Reports Wider Q2 Net Loss On Lower Revenues
Aug 7, 2024
10:28 AM EDT, 08/07/2024 (MT Newswires) -- Crescita Therapeutics ( CRRTF ) , down 4.5% at last look, earlier on Wednesday reported that second quarter net loss widened as revenue fell. The dermatology company's Q2 net loss widened to $0.926 million, or $0.05 per share basic and diluted, from a loss of near $0.3 million, or $0.01 per share, last...
Musk stirs UK divisions, sparks calls for faster rollout of online safety laws
Musk stirs UK divisions, sparks calls for faster rollout of online safety laws
Aug 7, 2024
* Government says online misinformation is fuelling riots * British Online Safety Bill set to come into effect next year * Some legislators, activists urge quicker implementation * Regulator says consultation must take place first By Martin Coulter LONDON, Aug 7 (Reuters) - Elon Musk has been accused of exacerbating tensions after a week of far-right rioting in Britain, sparking...
Copyright 2023-2026 - www.financetom.com All Rights Reserved